At EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. We have a long history of integrating cutting-edge science and innovative technology to develop products and devices that meet the needs of patients living with difficult-to-treat diseases. Today, our refocused pipeline is the strongest it has ever been, with more than 20 projects in clinical development focused on potential new oncolog...
At EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. We have a long history of integrating cutting-edge science and innovative technology to develop products and devices that meet the needs of patients living with difficult-to-treat diseases. Today, our refocused pipeline is the strongest it has ever been, with more than 20 projects in clinical development focused on potential new oncology and immuno-oncology medicines in more than 15 difficult-to-treat tumor types, as well as investigational treatments for psoriasis, lupus, multiple sclerosis, and other autoimmune diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.